Conference abstract · 16 Oct 2023
Conference abstractPublished 13 Jul 2018
Untitled abstract
University of Louisville, United States
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A 61-year-old Caucasian female presented to an outpatient clinic with easy bruising and was found to have platelets of 2x10³ /µL. She also reported easy bruising and was noted to have diffuses upper and lower extremity ecchymoses, along with true thrombocytopenia on peripheral smear, earning a diagnosis of idiopathic thrombocytopenic purpura (ITP). Following a failed attempt in quantitative recovery with platelet transfusion, high-dose dexamethasone and intravenous immunoglobulin (IVIG) were also attempted, unsuccessfully. The patient was then given rituximab, after which her platelets again remained low at 2-3 thousand/µL. The patient was ultimately given vincristine and was re-challenged with both high-dose steroids and IVIG, yielded a platelet recovery to 50 and 102 thousand/µL at two and seven days, respectively. ITP, which affects approximately 3.3 per 100,000 adults, has traditionally been managed with steroids and/or IVIG. Treatment for refractory ITP, however, is not as well-established. Various options, however, have been explored recently, one of which is the use of immunotherapy. Rituximab, for example, is reported to have an overall response rate of 60%, but with the caveat of only a 20-40% extended remission rate. Other groups have studied thrombopoietin receptor agonists (TPO-RAs), such as eltrombopag and romiplostim, which collectively maintain a sustained response in approximately 25% of patients. And perhaps the most novel approach to date, as in the presented case, is the use of Vinca alkaloids in combination with steroids and/or IVIG, with one study showing meaningful platelet recovery with such therapy in 75% of patients.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 12 Apr 2023
Untitled abstract
Conference abstract · 24 Aug 2021
Untitled abstract
Conference abstract · 24 May 2021
Untitled abstract
Conference abstract · 24 May 2021
Untitled abstract
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Samuel B Reynolds”
